Praxis Laboratory had their license suspended earlier this month for inflating numbers on potency test results, giving samples higher THC levels than the state actually found.
Major changes have occurred at the international level on cannabis in the last month. But what do they really mean going forward? And how do such decisions also interact with regional case law? Find out these answers and more in this year’s 2020 legislative and legal global cannabis roundup.
In the 15th episode of the 2020 Cannabis Quality Virtual Conference, check out “Creating an Industry-Wide Standard for CBD Quality and Efficacy” and “Heavy Metals in Hemp Extract Products.”
This MORE Act is a substantial step in cannabis legislation. While it doesn’t seem likely it’ll make it past the Senate, it signifies the progress that has been made and provides insight on what further legislation may look like.
Kennebec Analytical Services (KAS) announced last week that they have acquired Cannabis Testing Laboratories (CTL), whose parent company was Doane University.
In the 14th episode of the 2020 Cannabis Quality Virtual Conference, check out “The Cannabis Industry and Tax Implications of Entity Structure – Issues to Consider”
In this Q&A, we sit down with Ernest Toney, founder of BIPOCANN, to learn about his new project and how he hopes to increase representation and make the cannabis industry more accessible and profitable for BIPOC professionals and business owners.
With the House of Representatives voting to pass the Marijuana Opportunity Reinvestment and Expungement Act, the cannabis industry should celebrate this as the first federal legalization bill making its way through Congress. However, the win is largely symbolic as the bill is pretty much dead on arrival in the Senate.
November 3 was a historic night for legalization across the country. A decade ago, cannabis was illegal for nonmedical use in all 50 states. Now, five new states have made it onto the legalization map. Read on for an analysis of each state’s ballot initiative.
A United Nations commission voted to remove cannabis for medical use from Schedule IV classification, following the WHO recommendation to remove it from the strictest drug classification.
